Reading Time: 7 minutes
Return to Human Cloning and Stem Cell Research
Cloned Human Embryonic Stem Cells
Cloned human embryonic stem cells are derived from a cloned human embryo created by asexual reproduction. Somatic cell nuclear transfer (SCNT) is the scientific term for one of the asexual processes by which a human being or animal is cloned. SCNT involves a donor egg from which the nucleus has been removed. The enucleated egg is then fused with the nucleus from a cell of the person to be cloned, yielding a cloned human embryo that begins to divide and grow in the same fashion as an embryo created by traditional reproduction. This process of human somatic cell nuclear transfer is the identical method by which animals have been successfully cloned and birthed (e.g., Dolly the Sheep, CC the cat, cattle, etc.).
How are cloned embryonic stem cells obtained?
When the cloned human embryos reach 5 to 7 days, stem cells are extracted from the inner mass of the cloned embryos. Such dismemberment kills the cloned human embryo.
What diseases are being treated with cloned embryonic stem cells?
No health benefits or cures have been realized in animal trials using cloned human embryonic stem cells. This lack of clinical evidence, coupled with the appearance of dangerous side effects in animals (the formation of tumors), has discouraged the use of cloned embryonic stem cells in human clinical trials.
What are the challenges of using cloned embryonic stem cells?
Cloned human embryos are difficult to create. Only one laboratory in South Korea has created cloned human embryos and grown them to the point where stem cell extraction is possible. Hundreds of eggs were needed to create just one cloned embryo. In addition, animals injected with cloned embryonic stem cells have developed cancer and tumors due to the unpredictable and immature nature of the genetically altered and cloned embryonic stem cells.
What ethical concerns are linked to the use of cloned embryonic stem cells?
The use of cloned embryonic stem cells requires the creation of a human life solely for the purpose of lethal scientific experimentation, and therefore, carries serious ethical implications. Furthermore, regulations ensuring that these cloned human embryos will not be implanted in the womb to birth a human clone would be impossible to enforce.
How will a human cloning ban affect the use of cloned embryonic stem cells?
Cloned human embryonic stem cell research is the only type of stem cell research prohibited by a human cloning ban.
Embryonic Stem Cells
Embryonic stem cells are derived from the human embryos created for infertile couples at in vitro fertilization (IVF) clinics. In the laboratory, IVF clinics unite sperm from the father and an egg from the mother to create a child to implant in the mothers womb. Some parents decide not to implant and birth all their embryonic children; these left-over embryos may be placed for adoption, disposed of, or donated to research. In order to be used by scientists for research, parents must explicitly donate their embryonic children with informed consent, including clear acknowledgement that scientific experimentation will result in the death of their embryonic child.
How are embryonic stem cells obtained?
Embryonic stem cells are typically extracted after the frozen embryo is thawed and allowed to develop to four or five days old. Because the cells are taken from the inner cell mass of the embryo, the embryo dies during the extraction process. Embryonic stem cells extracted from donated embryos are used to start stem cell lines.
What diseases are currently treated with embryonic stem cells?
No illnesses or diseases have been treated using embryonic stem cells. In fact, embryonic stem cells have created tumors when tested in animals because of their immature and unpredictable nature. Furthermore, these cells are often rejected due to the DNA mismatch with the patient.
What are the challenges of using embryonic stem cells?
Embryonic stem cells are not used in human clinical trials because there have been no successes in animal trials. The development of tumors and terratomas (masses of flesh with eyes, hair, and teeth) has discouraged FDA approval of the use of embryonic stem cell transplants in humans. Embryonic stem cells are difficult to use because scientists have been unable to:
Establish and maintain stable cell lines of embryonic stem cells
What are the ethical concerns of using embryonic stem cells?
Embryos created for the purpose of in vitro fertilization are created with the intent to birth children. Extracting stem cells from embryos created for, but not used in, in vitro fertilization does result in the death of a unique human life and, consequently, encompasses serious ethical implications.
Would a comprehensive ban affect the use of embryonic stem cells?
Neither a state or federal ban on human cloning would prohibit in any way embryonic stem cell research that involves embryos created through in vitro fertilization, because IVF embryos are not created by cloning.
Fetal Stem Cells
Fetal stem cells are stem cells extracted from the tissues of aborted or miscarried unborn children in the fetal stage.
How are fetal stem cells obtained?
Fetal stem cells are extracted from a miscarried or aborted unborn child in the fetal stage through a tissue or blood sample. The tissue or blood sample is treated with growth factors in the laboratory, and then injected into the body of the diseased or injured patient.
What diseases are treated with fetal stem cells?
No medical treatment derived from fetal stem cells has successfully treated any human disease. In one of the most well-known human clinical trials using fetal stem cells, the cells were injected into the brains of Parkinsons patients. Unfortunately, these unpredictable young cells created terratomas (masses of tissue with hair and teeth) and tumors, and patients experienced increased Parkinsons symptoms.
What ethical concerns are linked to the use of fetal stem cells?
Although fetal stem cell research does not cause the death of the unborn child (as the child is already deceased at the time of extraction), ethical consideration must be given to research that depends on the death of an unborn child (especially if that death is unnaturally induced).
Will a human cloning ban affect fetal stem cell research?
A human cloning ban would not prohibit in any way the use of fetal stem cells.
Adult Stem Cells
Adult stem cells reside throughout the human body within tissue, blood and organs; they are plentiful and readily available. Adult stem cells do not have to come from an adult; rather, adult refers to the stage or maturity of the stem cell, distinguishing the cell from those stem cells extracted from pre-born humans (embryos and fetuses). Adult stem cells are also found in the tissues of the umbilical cord (after live birth), spinal cord, fat, bone marrow, dental pulp, nasal cavity, brain, peripheral blood, blood vessels, skeletal muscle, skin, cornea, digestive system, retina, liver, and pancreas.
How are adult stem cells obtained?
Adult stem cells are drawn from the body of the patient in a tissue or blood sample without harm to the individual. The cells are then transferred to the laboratory where they are cultured and coaxed to multiply. A dozen extracted adult stem cells may multiply into millions of new cells that are genetically identical to the original extracted cells. After the cells multiply, the healthy cells are re-inserted into the body of the patient where the cells differentiate into the appropriate cell type. Human clinical trials show that these new cells travel to the diseased or injured body part and begin repair and tissue regeneration.
What human diseases or conditions are currently treated with adult stem cells?
While adult stem cell research is by no means a perfected process, there are dozens of human diseases and conditions that have been successfully treated with adult stem cells.
To what is the success of adult stem cell therapies attributed?
Adult stem cells have had proven success in laboratory culture, animal models of disease, and in human clinical treatments. Adult stem cells:
What are the challenges of adult stem cell research?
Sometimes adult stem cells are difficult to identify or distinguish from other cells due to their abundant presence throughout the body and varying appearances depending on their location.
What ethical concerns are linked to the use of adult stem cells?
Unlike other types of stem cell research, the procurement and use of adult stem cells never requires the creation or destruction of innocent human life, and therefore, no ethical challenges arise.
How will a comprehensive cloning ban affect adult stem cell research?
A human cloning ban would not prohibit in any way the use of adult stem cells.
Visit link:
Four Types of Stem Cells - Texas Right to Life
- Cardiovascular Glossary A-Z (All) | Texas Heart Institute - January 4th, 2023
- ADC Therapeutics Announces Abstracts to be Presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022) - Business Wire - September 25th, 2022
- GVHD in the Context of Stem Cell or Allogeneic Transplant - Cancer Network - August 22nd, 2022
- De-extinction Company Aims to Resurrect the Tasmanian Tiger - Scientific American - August 22nd, 2022
- Dean Kamen on the power of celebrating your own obsoletion - TechCrunch - July 27th, 2022
- Westin and Sehn Carve Out the Role of CAR T-Cell Therapy and Transplant in Primary Refractory DLBCL - OncLive - July 27th, 2022
- Unanticipated findings cast new light on the genetic regulation of different brain tumors - Baylor College of Medicine - July 27th, 2022
- Chaotic response in Uvalde, Parkland shooter faces death penalty, mall shooting leaves 3 dead and jury selection begins in Bannon trial | Hot off the... - July 19th, 2022
- Stem Cells, Abortion, Baby Parts, & the Ukraine - Physicians for Life - June 22nd, 2022
- INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT - BioSpace - June 22nd, 2022
- Quizartinib Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy in Patients with Newly Diagnosed FLT3-ITD Positive... - June 13th, 2022
- Texas Family Fights to Access $2.1 Million Treatment for Baby - NBC 5 Dallas-Fort Worth - May 15th, 2022
- La Conner native raising funds to cure blood cancer - La Conner Weekly News - May 2nd, 2022
- CORRECTING and REPLACING -- Affimed NV - GlobeNewswire - May 2nd, 2022
- StudyFinds Blotter: Other Notable Health Research From April 28, 2022 - Study Finds - May 2nd, 2022
- Sung to lead cancer institute; Bankston wins fellowship - ASBMB Today - April 19th, 2022
- Houston teen first in Texas to become own donor to reverse sickle cell anemia - FOX 26 Houston - March 25th, 2022
- Oleic Acid, a Key to Activating the Brains Fountain of Youth - Neuroscience News - March 25th, 2022
- Stem Cell Therapy Boosts Outcomes for Some Heart Failure Patients - HealthDay - November 22nd, 2021
- Quizartinib Added to Chemotherapy Demonstrates Superior Overall Survival Compared to Chemotherapy Alone in Adult Patients with Newly Diagnosed... - November 22nd, 2021
- BioBridge Global continues history of innovation with umbilical cord collection and processing under cGMP standards for further manufacture - Yahoo... - November 22nd, 2021
- Immatics to Present Update on Lead ACTengine Program IMA203 Targeting PRAME at the Society for Immunotherapy of Cancers 36th Annual Meeting - Yahoo... - November 8th, 2021
- Affimed Announces Poster Presentations at the 63rd American Society of Hematology Annual ... - Tyler Morning Telegraph - November 8th, 2021
- ADC Therapeutics Announces Abstracts to be Presented at the 63rd ASH Annual Meeting - StreetInsider.com - November 8th, 2021
- The Power of the Immune System: New Treatment for Painful Blood Cancer Side Effect - Curetoday.com - October 28th, 2021
- Durham firm offering up to $10,000 for researchers to use its intestinal technology - WRAL Tech Wire - October 16th, 2021
- Elevated cryptic transcription emerges as a common theme in aging mammalian cells - Baylor College of Medicine News - August 31st, 2021
- Insulin-producing implants are being developed to control Type 1 diabetes - Health Europa - August 5th, 2021
- Cryptic Transcription in Mammalian Stem Cells Linked to Aging - Technology Networks - August 5th, 2021
- Overview of DLBCL - Targeted Oncology - August 5th, 2021
- The True Crime Junkies and the Curious Case of a Missing Husband - VICE - August 5th, 2021
- FROM THE LABS: Hispanic Heritage Spotlight: Interview with Dr. Nino Rainusso - Baylor College of Medicine News - November 13th, 2020
- UPMC nurse practitioner hailed 'healthcare hero' on live TV - Altoona Mirror - October 31st, 2020
- BrainStrom Cell Therapeutics (NASDAQ:BCLI) Enters Agreement With Catalent (NYSE:CTLT) For Manufacture Of Its NurOwn Cell Therapy - BP Journal - October 31st, 2020
- Dr. Daisy Ayim, Cosmetic Surgeon, ObGyn, Business Owner and Entrepreneur, Is Revolutionizing The Integration Of Women's Health And Cosmetic Care -... - October 31st, 2020
- Five Indian American Researchers Named Among NIH 2020 New Innovator Awardees - India West - October 21st, 2020
- Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma - Science... - October 21st, 2020
- Biotechnology could change the cattle industry. Will it succeed? - Salon - September 8th, 2020
- STEM CELLS | VitaDrip IV Therapy | Texas - June 26th, 2020
- New Preclinical Data Demonstrates Immune-Enhancing Effects of Triple I/O Combination Therapy with BeyondSpring's Plinabulin - BioSpace - June 23rd, 2020
- Tau: Why Alzheimer's Worsens Fast in Some, Slowly in Others - Alzforum - June 23rd, 2020
- Scholarly Perspectives on COVID-19, Part 1: This Was Only a Matter of Time - Southern Newsroom - June 23rd, 2020
- Texas Stem Cell Law Opens Door for Controversial Treatments - June 11th, 2020
- Who's to blame? These three scientists are at the heart of the Surgisphere COVID-19 scandal - Science Magazine - June 9th, 2020
- FTC ramps up enforcement with new wave of warning letters - NutraIngredients-usa.com - June 9th, 2020
- UT Student Awarded Prestigious Astronaut Scholarship - UT News | The University of Texas at Austin - June 9th, 2020
- South Sound Community Bands Together To Save Local Lives - southsoundtalk.com - May 7th, 2020
- Pfizer, NYU working on innovative coronavirus vaccine that could be ready by end of summer - NBC News - May 7th, 2020
- How industry hopes to take on COVID-19 - Bioprocess Insider - BioProcess Insider - March 8th, 2020
- Meng Hsieh, Andrew Shubin - The New York Times - March 8th, 2020
- Jimbo Fisher's Kidz1stFund, Aggie Corps of Cadets team up for Be the Match bone marrow donor registry drive - Bryan-College Station Eagle - March 2nd, 2020
- Texas A&M Researcher Named To National List Of Inspiring Black Scientists - Texas A&M University - March 2nd, 2020
- What to do in Madison: March 2-8, 2020 - The Bozho - March 2nd, 2020
- Cumberland County family turns to non-FDA approved stem cell treatment to help two-year-old son with cerebral palsy - FOX43.com - February 27th, 2020
- Recombinetics Announces Collaboration with University of Texas Southwestern to Advance Regenerative Medicine Through Therapeutic Cell, Tissue, and... - February 27th, 2020
- Stem Cell Therapy for Joints & Spine in Austin Texas - January 28th, 2020
- El Paso scientists to deliver 3D bioprinted miniature hearts to the ISS - 3D Printing Industry - January 28th, 2020
- El Paso scientists team up for heart research project at the International Space Station - KVIA El Paso - January 28th, 2020
- Drugs, Biologics, and Regenerative Medicine in 2019: A Successful Year Ends with Promise of a More Challenging 2020 - JD Supra - December 18th, 2019
- Incoming Faculty Bring New Areas of Research to Rensselaer - Rensselaer Polytechnic Institute - September 24th, 2019
- Nivolumab as an addition to frontline therapy of AML in younger patients - AML Global Portal - September 24th, 2019
- Interview: BIOLIFE4D is The First US Company to Bioprint a Mini-Heart (for Cardiotoxicity Testing) - 3DPrint.com - September 24th, 2019
- Stem cells regrow leg's long bones - WNDU-TV - September 22nd, 2019
- A breakthrough in the battle against citrus greening - Gainesville Sun - September 22nd, 2019
- Comparing Mymetics (OTCMKTS:MYMX) & Crispr Therapeutics (OTCMKTS:CRSP) - TechNewsObserver - September 22nd, 2019
- STEM CELL THERAPY & TREATMENTS Texas Regional Health - September 10th, 2019
- Fast Facts: Stem Cells 101 Vital Record - September 10th, 2019
- Keller, TX Stem Cells | Neuropathy & Pain Centers of Texas - May 31st, 2019
- Arlington Stem Cells | Neuropathy & Pain Centers of Texas - May 1st, 2019
- Houston, Texas Stem Cell Transplants, Richmond, Sugar Land ... - April 21st, 2019
- Fort Worth Stem Cells | Neuropathy and Pain Centers of Texas - April 15th, 2019
- Stem Cell Rejuvenation Therapy | Totalhormonegenetherapy.com - April 15th, 2019
- Our Doctors - Knee Stem Cells - March 17th, 2019
- Stem Cell Treatment Center in Dallas, Texas | Stem Cell ... - March 17th, 2019
- Neuropathy & Pain Centers of Texas - Stem Cells & Neuropathy - February 6th, 2019
- Stem Cell Doctor Dallas Dr. Darcy Brunk | Dallas, Plano ... - January 25th, 2019
- Texas | The Stem Cellar - December 5th, 2018
- Dallas, Texas, Stem Cells Treatment, Legal, Ft. Worth ... - November 16th, 2018
- HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex - October 13th, 2018
- Shooting Up Stem Cells With Ben Greenfield The Down The ... - September 16th, 2018